Antibody to combat HIV infection under trial

Antibody to combat HIV infection under trial
Researchers in the US aim to infuse an antibody into human immunodeficiency virus (HIV)-negative men.

Those enrolled will either be given intravenous infusions of VRC01 or a placebo every eight weeks for a total of 10 infusions. Participants will be closely monitored for approximately 22 months for safety and also to determine whether they have remained HIV-negative. HIV continues to be a major global public health issue, though the rate of infection has fallen significantly in recent years. In 2014, gay and bisexual men accounted for an estimated 83 per cent of all new HIV infections among men in the US, according to the Centers for Disease Control (CDC). Though the number of new HIV diagnoses fell 19 per cent from 2005 to 2014, certain demographic groups showed increases in the infection, CDC noted. ‘According to CDC estimates, only about 25 per cent of people who are HIV-positive have it under control,’ says Swaminathan. Know more about the factors that increase your risk for HIV, click here.

Source: IANS

Image source: Shutterstock

Disclaimer: TheHealthSite.com does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

Previous Article

600 malnutritioned kids' death issue: Maharashtra minister asks, 'So what?'

Next Article

Health ministry will support states affected by dengue and chikungunya: health minister